These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9103518)

  • 1. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
    Acquas E; Wilson C; Fibiger HC
    J Pharmacol Exp Ther; 1997 Apr; 281(1):360-8. PubMed ID: 9103518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
    Damsma G; Robertson GS; Tham CS; Fibiger HC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition.
    Acquas E; Fibiger HC
    J Neurochem; 1998 Mar; 70(3):1088-93. PubMed ID: 9489729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ; Randall S; Chase TN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum.
    Zackheim J; Abercrombie ED
    Neuroscience; 2005; 131(2):423-36. PubMed ID: 15708484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic regulation of cortical acetylcholine release.
    Day J; Fibiger HC
    Synapse; 1992 Dec; 12(4):281-6. PubMed ID: 1465741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum.
    Consolo S; Girotti P; Russi G; Di Chiara G
    J Neurochem; 1992 Oct; 59(4):1555-7. PubMed ID: 1402904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.
    Reid RT; Lloyd GK; Rao TS
    Br J Pharmacol; 1999 Jul; 127(6):1486-94. PubMed ID: 10455300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is in vivo striatal acetylcholine output under a tonic inhibitory control by dopamine?
    Imperato A; Obinu MC; Gessa GL
    J Neural Transm Suppl; 1995; 45():91-102. PubMed ID: 8748614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
    Pisanu A; Acquas E; Fenu S; Di Chiara G
    Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake rats.
    Antoniou K; Kehr J; Snitt K; Ogren SO
    Br J Pharmacol; 1997 Jul; 121(6):1180-6. PubMed ID: 9249255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.